Rare diseases
Investigational molecules
Locations
Back to Bulgaria35 clinical trials in Kozloduy, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.
Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
BulgariaA Phase III Randomized Double‑Blind Study of Elecoglipron for Adults with Type 2 Diabetes on Insulin
BulgariaZenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
BulgariaA study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness
BulgariaGB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents
BulgariaStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
BulgariaAsthma in adults: beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide compared with beclometasone dipropionate and formoterol fumarate dihydrate
BulgariaEfficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
BulgariaA study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.
BulgariaA study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease
BulgariaA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
BulgariaStudy of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on asthma treatments and management, including trials of new medications for moderate to severe cases. Studies evaluating various therapeutic approaches for patients with uncontrolled asthma symptoms.
Multiple trials testing innovative inhaler formulations and combination therapies.
Current studies examining treatments for respiratory viral infections, including influenza and COVID-19. Research includes evaluation of new vaccines and antiviral medications.
Focus on developing effective preventive measures and therapeutic interventions.
Comprehensive research into COPD and chronic kidney disease treatments. Studies evaluating new combination therapies and investigating disease progression control.
Trials aimed at improving quality of life and reducing disease progression.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
